No improvement in two measures deserves a different question
When both hemoglobin and ferritin stay low, clinicians examine adherence, ongoing blood loss and impaired absorption rather than simply extending tablets.
Several explanations may be worth exploring
- Inadequate tolerated oral dosingSide effects or an unsuitable regimen may limit the actual iron received.
- Ongoing menstrual or gastrointestinal blood lossContinued iron loss may exceed replacement even when tablets are taken.
- Celiac-associated malabsorptionSmall-intestinal disease may limit oral iron uptake, sometimes without prominent diarrhea.
- H. pylori or gastric pathologySelected stomach disorders can accompany iron deficiency or impair absorption.
- Chronic inflammationInflammatory physiology can alter iron indices and limit effective iron availability.
A detail to bring to the discussionIron formulation, elemental dose, timing and tolerance change whether oral treatment is an adequate trial.
This changes which questions to askYour answer can help your clinician choose which possibility deserves priority. When oral iron does not replenish stores, compare dose, timing, tolerance, ongoing loss and absorption before assuming the original diagnosis explains everything.
Unknown details can be clarifiedKeep original test and prescription dates if available; there is no need to guess what a report contained.
Another clue worth connectingContinued bleeding and poor absorption require different follow-up; more than one can coexist.
History can change the pictureThis answer helps connect findings across time, but the relationship still needs clinical interpretation.
A separate clue to discussBring the relevant history to your clinician; what matters depends on its onset and severity.
No extra clue does not exclude possibilitiesA brief scan cannot exclude causes. Further adaptive questions may clarify the picture.
